REFERENCES
- Kimura F, Florl AR, Seifert HH, Louhelainen J, Maas S, Knowles MA et al. Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder. Br J Cancer 2001; 85:1887–93.
- Knowles MA. Identification of novel bladder tumour suppressor genes. Electrophoresis 1999; 20:269–79.
- Gonzalez-Zulueta M, Bender CM, Yang A, Nguyen T, Heart RW, Van Tornout TM et al. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1995; 55:4531–5.
- UICC: TNM classification of malignant tumours. 3rd ed. Geneva, 1978.
- Hall RR, Prout GR. Staging of bladder cancer: is the tumour, node, metastasis system adequate? Sem Oncol 1990;17: 517–23.
- Bergkvist A, Ljungqvist A, Moberger G. Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 1965; 130: 371–8.
- Carbin BE, Ekman P, Gustafsson H, Christensen NJ, Sandstedt B, Silfversward C. Grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency. J. Urol 1991; 145: 968–71.
- Mostofi FK, Davies CJ, Sesterhenn IA. Histological typing of urinary bladder tumours. International classi-fication of tumours. No. 10 (ed2) Geneva 1999.
- Louhelainen J, Lindstrom E, Hemminki K, Toftgard R. Dinucleotide repeat polymorphism within the tumor suppressor gene PTCH at 9q22. Clin Gen 1998; 54: 239–41.
- Habuchi T, Ogawa O, Kakehi Y, Ogura K, Koshiba M, Hamazaki S, et al. Accumulated allelic losses in the development of invasive urothelial cancer. Int J Cancer 1993; 53: 579–84.
- Knowles MA, Elder PA, Williamson M, Cairns JP, Shaw ME. Law MG. Allelotype of human bladder cancer. Cancer Res 1994; 54: 531–8.
- Habuchi T, Devlin J, Elder PA, Knowles MA. Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci. Oncogene 1995; 11: 1671–4.
- Mahdy E, Yoshihiro S, Zech L, Wester K, Pan Y, Busch C, et al. Comparison of comparative genomic hybridiza-tion, fluorescence in situ hybridization and flow cyto-metry in urinary bladder cancer. Anticancer Res 1999; 19: 7–12.
- Jacobsen A, Arnold N, Weimer J, Kiechle M. Compari-son of comparative genomic hybridization and inter-phase fluorescence in situ hybridization in ovarian carcinomas: possibilities and limitations of both tech-niques. Cancer Genet Cytogenet 2000; 122: 7–12.
- Pinkel D, Landegent J, Collins C, Fuscoe J, Segraves R, Lucas J, et al. Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. Proc Natl Acad Sci U S A 1988; 85: 9138–42.
- Kallioniemi O-P, Kallioniemi A, Piper J, Isola J, Waldman F, Gray JW, et al. Optimising comparative genomic Hybridisaiton for the analysis of DNA sequence copy number changes in solid tumours. Gen chromo-somes Cancer 1994; 19: 10–26.
- McGarvey TW, Maruta Y, Tomaszewski JE, Linnenbach AJ. Malkowicz SB. PTCH gene mutations in invasive transitional cell carcinoma of the bladder. Oncogene 1998; 17: 1167–72.